Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

AstraZeneca says EU legal action over COVID-19 vaccine supply is without merit

Mon, 26th Apr 2021 13:28

LONDON, April 26 (Reuters) - AstraZeneca on Monday
said that legal action by the European Union against the
pharmaceutical company over the supply of its COVID-19 vaccine
was without merit and pledged to defend itself strongly in
court.

"AstraZeneca has fully complied with the Advance Purchase
Agreement with the European Commission and will strongly defend
itself in court. We believe any litigation is without merit and
we welcome this opportunity to resolve this dispute as soon as
possible," AstraZeneca said in a statement.
(Reporting by Alistair Smout)

Related Shares

More News
Today 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Today 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company rep...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.